Citigroup Inc Zai Lab LTD Transaction History

Citigroup Inc

$217 Billion
Q3 2025

A detailed history of Citigroup Inc transactions in Zai Lab LTD stock. As of the latest transaction made, Citigroup Inc holds 8,266 shares of ZLAB stock, worth $180,942. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,266

Previous 8,512 2.89%

Holding current value

$180,942

Previous $297,000 5.72%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$28.4 - $40.51 $6,986 - $9,965	-246 Reduced 2.89%	8,266 $280,000
Q2 2025 Aug 11, 2025	BUY	$24.32 - $43.03 $33,877 - $59,940	1,393 Added 19.57%	8,512 $297,000
Q1 2025 May 12, 2025	SELL	$24.29 - $38.35 $1.55 Million - $2.45 Million	-63,835 Reduced 89.97%	7,119 $257,000
Q4 2024 Feb 12, 2025	BUY	$24.61 - $33.18 $29,704 - $40,048	1,207 Added 1.73%	70,954 $1.86 Million
Q3 2024 Nov 12, 2024	SELL	$16.25 - $24.14 $572,910 - $851,079	-35,256 Reduced 33.58%	69,747 $1.68 Million
Q2 2024 Aug 12, 2024	BUY	$13.72 - $21.55 $1.42 Million - $2.22 Million	103,244 Added 5869.47%	105,003 $1.82 Million
Q1 2024 May 10, 2024	SELL	$15.95 - $26.8 $14,689 - $24,682	-921 Reduced 34.37%	1,759 $28,000
Q4 2023 Feb 09, 2024	SELL	$22.97 - $30.58 $2.82 Million - $3.76 Million	-122,808 Reduced 97.86%	2,680 $73,000
Q3 2023 Nov 09, 2023	SELL	$22.72 - $31.49 $5,225 - $7,242	-230 Reduced 0.18%	125,488 $3.05 Million
Q2 2023 Aug 10, 2023	SELL	$25.3 - $39.67 $9.79 Million - $15.3 Million	-386,852 Reduced 75.47%	125,718 $3.49 Million
Q1 2023 May 11, 2023	BUY	$30.21 - $48.1 $13.5 Million - $21.5 Million	446,515 Added 675.97%	512,570 $17 Million
Q4 2022 Feb 09, 2023	SELL	$22.28 - $38.71 $979,116 - $1.7 Million	-43,946 Reduced 39.95%	66,055 $2.03 Million
Q3 2022 Nov 10, 2022	SELL	$34.2 - $51.69 $491,248 - $742,475	-14,364 Reduced 11.55%	110,001 $3.76 Million
Q2 2022 Aug 10, 2022	BUY	$23.14 - $49.68 $3,424 - $7,352	148 Added 0.12%	124,365 $4.31 Million
Q1 2022 May 12, 2022	BUY	$27.77 - $64.4 $2.43 Million - $5.63 Million	87,400 Added 237.39%	124,217 $5.46 Million
Q4 2021 Feb 10, 2022	SELL	$54.9 - $105.21 $79,001 - $151,397	-1,439 Reduced 3.76%	36,817 $2.31 Million
Q3 2021 Nov 10, 2021	BUY	$105.0 - $178.37 $4.02 Million - $6.82 Million	38,256 New	38,256 $4.03 Million

Others Institutions Holding ZLAB

# of Institutions

166

Shares Held

37.7M

Call Options Held

150K

Put Options Held

201K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.14B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account